Search Results - "Nistico, Robert"
-
1
Aducanumab for Alzheimer’s disease: A regulatory perspective
Published in Pharmacological research (01-09-2021)“…On June 7th 2021, the Food and Drug Administration (FDA) granted approval for Aduhelm (aducanumab) for the treatment of Alzheimer’s disease under its…”
Get full text
Journal Article -
2
Neurodegenerative Disease: What Potential Therapeutic Role of Acid-Sensing Ion Channels?
Published in Frontiers in cellular neuroscience (08-10-2021)“…Acidic pH shift occurs in many physiological neuronal activities such as synaptic transmission and synaptic plasticity but also represents a characteristic…”
Get full text
Journal Article -
3
The β-Secretase BACE1 in Alzheimer’s Disease
Published in Biological psychiatry (1969) (15-04-2021)“…BACE1 (beta-site amyloid precursor protein cleaving enzyme 1) was initially cloned and characterized in 1999. It is required for the generation of all…”
Get full text
Journal Article -
4
Targeting Microglia-Synapse Interactions in Alzheimer's Disease
Published in International journal of molecular sciences (26-02-2021)“…In this review, we focus on the emerging roles of microglia in the brain, with particular attention to synaptic plasticity in health and disease. We present…”
Get full text
Journal Article -
5
A Path Toward Precision Medicine for Neuroinflammatory Mechanisms in Alzheimer's Disease
Published in Frontiers in immunology (31-03-2020)“…Neuroinflammation commences decades before Alzheimer's disease (AD) clinical onset and represents one of the earliest pathomechanistic alterations throughout…”
Get full text
Journal Article -
6
Acid-sensing ion channel 1a: a novel target in Alzheimer's disease?
Published in Neural regeneration research (01-02-2023)Get full text
Journal Article -
7
SUMO: a (Oxidative) Stressed Protein
Published in Neuromolecular medicine (01-12-2013)“…Redox species are produced during the physiological cellular metabolism of a normal tissue. In turn, their presence is also attributed to pathological…”
Get full text
Journal Article -
8
Editorial: Neurotrophins Biodelivery to CNS: Innovative Approaches for Disease-Modifying Therapy
Published in Frontiers in neuroscience (10-05-2022)Get full text
Journal Article -
9
Plasma ATN(I) classification and precision pharmacology in Alzheimer's disease
Published in Alzheimer's & dementia (01-10-2023)“…Evaluating potential therapies for Alzheimer's disease (AD) depends on use of biomarkers for appropriate subject selection and monitoring disease progression…”
Get full text
Journal Article -
10
Pharmacological targeting of microglia dynamics in Alzheimer’s disease: Preclinical and clinical evidence
Published in Pharmacological research (01-10-2022)“…Numerous clinical trials of anti‐amyloid agents for Alzheimer’s disease (AD) were so far unsuccessful thereby challenging the validity of the amyloid…”
Get full text
Journal Article -
11
The Involvement of Post-Translational Modifications in Alzheimer's Disease
Published in Current Alzheimer research (22-02-2018)“…Alzheimer's disease (AD) is a neurodegenerative disorder recognized as the most common cause of chronic dementia among the ageing population. AD is…”
Get more information
Journal Article -
12
Exploiting Focused Ultrasound to Aid Intranasal Drug Delivery for Brain Therapy
Published in Frontiers in pharmacology (14-04-2022)“…Novel effective therapeutic strategies are needed to treat brain neurodegenerative diseases and to improve the quality of life of patients affected by…”
Get full text
Journal Article -
13
Unlocking the secrets of dopamine in Alzheimer’s Disease
Published in Pharmacological research (01-02-2018)Get full text
Journal Article -
14
Defining and assessing intrinsic capacity in older people: A systematic review and a proposed scoring system
Published in Ageing research reviews (01-08-2022)“…The World Health Organization has introduced the term ‘intrinsic capacity’ (IC) as a marker of healthy ageing. However, controversy exists on the definition…”
Get full text
Journal Article -
15
Omics sciences for systems biology in Alzheimer’s disease: State-of-the-art of the evidence
Published in Ageing research reviews (01-08-2021)“…[Display omitted] •A systems-level approach allows untangling AD upstream pathomechanistic alterations.•Multi-omics approaches hold the potential to generate…”
Get full text
Journal Article -
16
Therapeutic potential of targeting hydrogen peroxide metabolism in the treatment of brain ischaemia
Published in British journal of pharmacology (01-06-2012)“…For many years after its discovery, hydrogen peroxide (H2O2) was viewed as a toxic molecule to human tissues; however, in light of recent findings, it is being…”
Get full text
Journal Article -
17
Targeting Synaptic Dysfunction in Alzheimer’s Disease Therapy
Published in Molecular neurobiology (01-12-2012)“…In the past years, major efforts have been made to understand the genetics and molecular pathogenesis of Alzheimer’s disease (AD), which has been translated…”
Get full text
Journal Article -
18
Effects of physical activity and exercise interventions on Alzheimer’s disease: an umbrella review of existing meta-analyses
Published in Journal of neurology (01-02-2023)“…Introduction During the last decade, physical activity (PA) (or “exercise”) has been identified as one of the main modifiable factors that influence the…”
Get full text
Journal Article -
19
Are we close to using Alzheimer blood biomarkers in clinical practice?
Published in Neural regeneration research (01-12-2024)Get full text
Journal Article -
20
Alzheimer’s disease: understanding homeostasis deregulation to foster development of effective therapies
Published in Pharmacological research (01-01-2019)Get full text
Journal Article